Phase II studies of BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesophageal adenocarcinoma

This publication has 7 references indexed in Scilit:

• Clinical and pharmacological phase I study with accelerated titration design of a daily times five schedule of BBR3464, a novel cationic triplatinum complex
  Annals of Oncology, 2000
• New Guidelines to Evaluate the Response to Treatment in Solid Tumors
  JNCI Journal of the National Cancer Institute, 2000
• Consequences of Nucleic Acid Conformation on the Binding of a Trinuclear Platinum Drug
  Biochemistry, 1999
• A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts
  British Journal of Cancer, 1999
• 1180: First demonstration of anti-lymphoma activity of BCL-2 antisense molecule-G3139; Results of phase I/IIA clinical trial
  European Journal Of Cancer, 1997
• A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF)
  Annals of Oncology, 1994
• The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent
  Journal of Chronic Diseases, 1961